Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone-Reference-Cited by-同舟云学术

Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone

Published:2007-10-01 Issue:4 Volume:9 Page:438-446
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Maillo Angel,Orfao Alberto,Espinosa Ana B.,Sayagués José María,Merino Marta,Sousa Pablo,Lara Monica,Tabernero María Dolores

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/9/4/438/13066570/NO94_09_Maillo.pdf

Reference56 articles.

1. Fewings PE, Battersby RD, Timperley WR. Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence? J Neurosurg. 2000;92: 401-405.

2. Hsu DW, Efird JT, Hedley-Whyte ET. MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol Appl Neurobiol. 1998;24: 441-452.

3. Maes L, Kalala JP, Cornelissen M, de Ridder L. PCNA, Ki-67 and hTERT in residual benign meningiomas. In Vivo. 2006;20: 271-275.

4. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer. 1998;82: 2262-2269.

5. Roser F, Nakamura M, Bellinzona M, Rosahl SK, Ostertag H, Samii M. The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol. 2004;57: 1033-1037.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-parameter MRI radiomic features may contribute to predict progression-free survival in patients with WHO grade II meningiomas;Frontiers in Oncology;2024-06-28

2. The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care;Cancers;2024-04-30

3. Medical Management of Meningiomas;Neurosurgery Clinics of North America;2023-07

4. Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas;Journal of Neuro-Oncology;2023-06

5. Male sex and presence of preoperative symptoms are associated with early recurrence of WHO grade I meningiomas after surgical resection: analysis from the nationwide Brain Tumor Registry of Japan;Neurosurgical Review;2022-12-09